5-Amino-1MQ — NNMT inhibitor and the NAD+ pathway in research

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule compound studied as a selective inhibitor of the enzyme NNMT — nicotinamide N-methyltransferase. Unlike peptides, it is not a protein fragment but a small molecule based on a quinolinium core, designed in pharmacology laboratories as a so-called research tool (tool compound) for switching off the activity of one specific enzyme.

Interest in 5-Amino-1MQ in the literature stems from the position NNMT occupies in cellular metabolism. This enzyme sits at the intersection of two important pathways: the availability of NAD+ (through the consumption of nicotinamide) and methylation metabolism (through the consumption of SAM, the main donor of methyl groups). For this reason the compound is analysed as a mechanistic tool for studying what happens in an experimental system when NNMT activity is reduced — not as a product with a defined effect in humans.

Mechanism in brief

NNMT catalyses the transfer of a methyl group from SAM (S-adenosyl-L-methionine) to nicotinamide, forming 1-methylnicotinamide (1-MNA) and SAH. Following the "lock and key" principle, 5-Amino-1MQ fits into the enzyme's active site and competes with its natural substrate, limiting this methyl transfer.

The mechanistic consequence studied in models is twofold: less nicotinamide is diverted into 1-MNA (which theoretically leaves a larger pool of precursor for the salvage pathway that rebuilds NAD+, driven by the enzyme NAMPT), and less SAM is consumed in this reaction. This makes 5-Amino-1MQ a precise tool — acting more like a screwdriver than a hammer — allowing the role of NNMT alone to be isolated without interfering with the entire metabolic network.

What is the subject of research

The areas below describe what is analysed and in which models. These are not effects in humans but directions of laboratory observation.

• Adipocyte metabolism — in adipocyte cell lines and in mouse models with elevated NNMT expression, researchers analysed how the enzyme's activity relates to the pathways of lipid metabolism and energy expenditure in the context of the NAD+/SAM axis. The subject of analysis is cell biochemistry, not body mass.
• NAD+ availability — biochemical and cellular studies examined the relationship between NNMT activity and the salvage pathway, which rebuilds NAD+ from nicotinamide. For this reason 5-Amino-1MQ is sometimes analysed alongside NAD+-raising interventions such as NR precursors (nicotinamide riboside) or NMN.
• Tumour metabolism — overexpression of NNMT has been described in many tumour cell lines in vitro; there the compound serves as a tool for studying the enzyme's influence on methylation potential (the SAM/SAH ratio) and epigenetic processes. This is the study of a mechanism in a model, not a therapeutic intervention.
• Metabolic homeostasis in animal models — in rodent models related to metabolic disorders, researchers analysed how pharmacological inhibition of NNMT affects tissue metabolic markers. These observations require further research and do not translate directly to human physiology.

Origin and historical context

NNMT was described as a nicotinamide-methylating enzyme as early as the mid-twentieth century, within the line of work on SAM-dependent methyltransferases. Its metabolic significance — its links to NAD+, SAM and adipose tissue biology — however only became the subject of intensive research in the last two decades, when elevated expression of the enzyme was noticed in metabolic and tumour tissues.

5-Amino-1MQ arose within this line of work as a purposefully designed small-molecule inhibitor based on a quinolinium scaffold, developed by groups working on NNMT pharmacology as a selective tool for switching off the enzyme in experimental systems. Its value in science lies precisely in its specificity — it allows the effects of inhibiting a single enzyme to be studied without simultaneously disturbing related pathways.

Research specification

In research supply, 5-Amino-1MQ most often occurs as a high-purity lyophilisate (powder), stored under conditions that limit exposure to light and moisture. The quality standard applied is purity analysis by HPLC, which confirms the identity and content of the compound. This is a quality parameter of the material, not a promise of any biological effect.

Analytical data for a given batch — including the purity profile and safety information — should be verified each time against the documentation supplied with the material. The relevant sheets and information are available in the safety data sheets section.

Level of evidence

Honestly about the limits of the data: knowledge of 5-Amino-1MQ rests mainly on in vitro studies (enzymatic assays, cell lines) and on animal models, primarily rodents. Data from human studies are limited or unavailable, and the translation of observations from cellular and animal systems to the human body remains unconfirmed.

Each of the directions described — from the NAD+/SAM axis to adipocyte metabolism — should be treated as a mechanistic hypothesis requiring further research, not as an established physiological fact.

For research purposes only. Not for human or animal consumption. Material intended for laboratory and scientific use; it is not a medicinal product, dietary supplement or foodstuff.